LONDON — Patients who received a liver transplant had significantly reduced antibody and T-cell responses to SARS-CoV-2 vaccination compared with healthy controls, according to research presented at the International Liver Congress.
“Emerging data have demonstrated suboptimal immune responses to SARS-CoV-2 vaccination in immunosuppressed cohorts,” Thomas Marjot, a clinical research training fellow at the Oxford Liver Unit at Oxford University Hospitals NHS Foundation Trust, and colleagues wrote. Read more in Healio.